Cochrane Abstracts
Oral and intrauterine progestogens for atypical endometrial hyperplasia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral and Intrauterine Progestogens for Atypical Endometrial Hyperplasia." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432691/all/Oral_and_intrauterine_progestogens_for_atypical_endometrial_hyperplasia.
Oral and intrauterine progestogens for atypical endometrial hyperplasia. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432691/all/Oral_and_intrauterine_progestogens_for_atypical_endometrial_hyperplasia. Accessed January 21, 2025.
Oral and intrauterine progestogens for atypical endometrial hyperplasia. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432691/all/Oral_and_intrauterine_progestogens_for_atypical_endometrial_hyperplasia
Oral and Intrauterine Progestogens for Atypical Endometrial Hyperplasia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432691/all/Oral_and_intrauterine_progestogens_for_atypical_endometrial_hyperplasia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral and intrauterine progestogens for atypical endometrial hyperplasia
ID - 432691
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432691/all/Oral_and_intrauterine_progestogens_for_atypical_endometrial_hyperplasia
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
